FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden-High Solid Tumors.
Marcus L, Fashoyin-Aje LA, Donoghue M, Yuan M, Rodriguez L, Gallagher PS, Philip R, Ghosh S, Theoret MR, Beaver JA, Pazdur R, Lemery SJ.
Marcus L, et al. Among authors: yuan m.
Clin Cancer Res. 2021 Sep 1;27(17):4685-4689. doi: 10.1158/1078-0432.CCR-21-0327. Epub 2021 Jun 3.
Clin Cancer Res. 2021.
PMID: 34083238
Free PMC article.